Losartan Sandoz 50 mg - Filmtabletten
Recall
|
Medicines
|
21/09/2021
The marketing authorisation holder informed its customers on September 21, 2021 that laboratory analyses of the active ingredient used in the mentioned batches have revealed azido contamination above the acceptable limit.
For this reason, the affected batches are recalled.
| Name of the medicinal product | Losartan Sandoz 50 mg - Filmtabletten |
|---|---|
| Marketing authorisation number(s) | 1-27047 |
| CIP code | 3515905 |
| Marketing authorisation holder | Sandoz GmbH |
| Batch number(s) | batches, expiry date KC 2277, 07.2022 KM5233, 02.2023 KZ9888, 03.2023 KZ9889, 03.2023 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-3634 |
